Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05379231
Other study ID # 461
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 11, 2022
Est. completion date March 21, 2023

Study information

Verified date March 2023
Source Sonova AG
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

23 candidates for BiCROS hearing aids will be recruited and fitted with a hearing aid and a CROS device. Following a real-world trial, each participant will be tested on a range of outcome measures including speech recognition in noise, ratings of listening effort, and ratings of preference.


Description:

Unilateral Hearing Loss (UHL) can be defined as any degree of permanent hearing loss on one ear with normal hearing in the opposite ear. Unilateral hearing loss can be debilitating associated with audiological, psychosocial and educational challenges. Audiological challenges include the reduced ability to localize sounds, reduced awareness on the unaidable side and difficulties hearing in noise or at a distance. One solution for unaidable UHL is Contralateral Routing of Signals (CROS) and Bilateral Contralateral routing of signals (BiCROS) using a so-called CROS transmitter together with a hearing aid. The rationale for this clinical investigation is to collect clinical data with a rechargeable CROS transmitter to evaluate the benefits of a BiCROS fitting compared to the alternative treatment option, the monaural hearing aid fitting, and to no treatment in noisy listening situations. Hearing tests, ear impressions and hearing aid fitting visits are mainly conducted at the National Centre for Audiology in London, Ontario. Those visits are available at the Sonova Innovation Centre Toronto in Mississauga, Ontario, upon request. Outcome measurements are only conducted at the National Centre for Audiology in London, Ontario.


Recruitment information / eligibility

Status Completed
Enrollment 19
Est. completion date March 21, 2023
Est. primary completion date March 21, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria: - unaidable hearing loss in worse ear (>N6) - aidable hearing loss (N3 to N5) on the other ear - fluent English speaker Exclusion Criteria: - aidable hearing loss in both ears

Study Design


Related Conditions & MeSH terms


Intervention

Other:
BiCROS fitting
Each participant will be fitted with the experimental CROS device on the unaidable ear and with a compatible hearing aid on the other ear.
Monaural hearing aid fitting
Each participant will be fitted with a hearing aid on the better hearing ear and no device on the unaidable ear. Monaural hearing aid fitting acts as control intervention.
Unaided condition
No treatment, i.e. the participants are not fitted with a CROS device and/ or hearing aid. Unaided condition acts as control intervention.

Locations

Country Name City State
Canada National Centre for Audiology London Ontario
Canada Sonova Innovation Centre Toronto Mississauga Ontario

Sponsors (2)

Lead Sponsor Collaborator
Sonova AG Western University, Canada

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Speech intelligibility in Noise measured with US Matrix Test (noise from a defined loudspeaker) Measuring the Signal to Noise Ratio change in decibels for speech from the front loudspeaker and noise from the better ear's side 7 months
Secondary Speech intelligibility in Noise measured with US Matrix Test (diffuse noise) Measuring the Signal to Noise Ratio change in decibels for speech from the front loudspeaker in surrounding noise 7 months
Secondary Reports of Subjective quality of hearing as assessed by the SSQ Measured after home trial with the Speech, Spatial and Qualities of Hearing Scale (Gatehouse, 2004) 7 months
Secondary Reports of Subjective quality of hearing as assessed by the Bern Benefit Questionnaires Measured after home trial with the Bern Benefit in Single-Sided Deafness Questionnaire (Komps et al, 2011) 7 months
Secondary Sound quality ratings for Total Impression and Clarity using Gabriellson et al (1990) Ratings Scales Ratings of speech in quiet and in noise presented via loudspeakers 7 months
Secondary Subjective preference of hearing aid condition 3 alternative forced choice (A, B, no preference or ABX) paradigm with three repetitions for speech in noise presented via loudsepakers 7 months
Secondary Listening effort in noise using 7 point scale (Johnson et al, 2015) Measuring listening effort for speech in multi-talker babble presented via loudspeaker 7 months
See also
  Status Clinical Trial Phase
Completed NCT03807713 - Clinical Study of Minimally Invasive Ponto Surgical Technique (MIPS) - Design Iteration N/A
Recruiting NCT04793412 - Cochlear Implantation in Children With Asymmetric Hearing Loss or Single-Sided Deafness Clinical Trial N/A
Withdrawn NCT01264510 - Evaluation of the Effectiveness of Bone-anchored Hearing Aids (Baha) Phase 4
Completed NCT03281967 - Clinical Survey of Minimally Invasive Ponto Surgical Technique (MIPS) N/A
Recruiting NCT05775367 - Cochlear Implants in Young Children With SSD N/A
Recruiting NCT05435612 - Evaluation of Rehabilitation Results in the Single-sided Deafness With Cochlear Implantation N/A
Completed NCT00201617 - Efficacy of the Bone-anchored Hearing Aid for Unilateral Deafness N/A
Completed NCT01715948 - Comparison of BAHA and CROS Hearing Aid in Single-Sided Deafness N/A
Terminated NCT00589407 - Unilateral Blindness/ Unilateral Deafness-relation to Neck Pain N/A